Patricia Hurter is the founder of Lyndra Therapeutics. Lyndra Therapeutics has raised $146M in total funding. Latest round: Series B. Based in Cambridge, MA.
Patricia Hurter is the Chief Executive Officer of Lyndra Therapeutics, a clinical-stage biopharmaceutical company developing long-acting oral therapies. She joined Lyndra as CEO on September 3, 2019, to lead its pivotal trials for schizophrenia and bipolar disorder treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide